PolyModels Hub, a London-based startup developing software for the pharmaceutical industry has closed a £7m Series A round a year after raising its seed.
Founded in 2023, PolyModels Hub has created ModelFlow, a digital platform that brings together advanced modeling, simulation and workflow management for researchers to design, test and define biopharma manufacturing processes.
Having raised £1.1m in a seed investment led by Marathon Venture Capital last year, the company has now greatly expanded its war chest as it looks to expand its engineering and product teams, enhance its platform and a reach a greater number of international pharmaceutical organisations.
“The pharmaceutical industry is undergoing a once-in-a-generation digital transformation. In just 18 months, our technology and exceptional team have delivered tangible value across multiple programs, expanding these collaborations to a global scale,” said PolyModels Hub co-founder and chief executive Antonio Benedetti.
“We’re investing deeply in complex biologics and advancing our platform to empower scientists with the model-based solutions they deserve to transform molecules into medicines for the 21st century.”
The Series A round was led by Molten Ventures and included a follow-on investment from Marathon Venture Capital.
“PolyModels Hub is solving a real pain point for pharma teams, bringing together deep domain expertise and cutting-edge technology in a way that’s genuinely transformative,” said Molten Ventures chief executive Ben Wilkinson.
“What impressed us most is the team’s blend of technical know-how and deep understanding of their customers’ challenges. They’ve built a solution that delivers value in weeks, not years, and its rapid adoption across the industry speaks volumes.”
